These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33499885)

  • 21. Prediction of the enhanced insulin absorption across a triple co-cultured intestinal model using mucus penetrating PLGA nanoparticles.
    Jaradat A; Macedo MH; Sousa F; Arkill K; Alexander C; Aylott J; Sarmento B
    Int J Pharm; 2020 Jul; 585():119516. PubMed ID: 32525079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scalable production of core-shell nanoparticles by flash nanocomplexation to enhance mucosal transport for oral delivery of insulin.
    He Z; Liu Z; Tian H; Hu Y; Liu L; Leong KW; Mao HQ; Chen Y
    Nanoscale; 2018 Feb; 10(7):3307-3319. PubMed ID: 29384554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery.
    Kulkarni SA; Feng SS
    Pharm Res; 2013 Oct; 30(10):2512-22. PubMed ID: 23314933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic insight into the interaction of gastrointestinal mucus with oral diblock copolymers synthesized via ATRP method.
    Liu J; Cao J; Cao J; Han S; Liang Y; Bai M; Sun Y
    Int J Nanomedicine; 2018; 13():2839-2856. PubMed ID: 29805260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs.
    He C; Yin L; Tang C; Yin C
    Biomaterials; 2012 Nov; 33(33):8569-78. PubMed ID: 22906606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucus-penetrating dendritic mesoporous silica nanoparticle loading drug nanocrystal clusters to enhance permeation and intestinal absorption.
    Zhou W; Li B; Min R; Zhang Z; Huang G; Chen Y; Shen B; Zheng Q; Yue P
    Biomater Sci; 2023 Jan; 11(3):1013-1030. PubMed ID: 36545798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Intestinal Absorption Mechanism and Pharmacokinetics of Curcumin-Loaded Galactosylated Albumin Nanoparticles.
    Huang Y; Deng S; Luo X; Liu Y; Xu W; Pan J; Wang M; Xia Z
    Int J Nanomedicine; 2019; 14():9721-9730. PubMed ID: 31849464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption.
    Li Y; Yang B; Zhang X
    Int J Pharm; 2019 Sep; 568():118508. PubMed ID: 31299337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
    Joshi G; Kumar A; Sawant K
    Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery.
    Iglesias T; López de Cerain A; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A
    Int J Pharm; 2017 Jan; 517(1-2):67-79. PubMed ID: 27908629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
    Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
    Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
    Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
    J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral delivery system for low molecular weight protamine-dextran-poly(lactic-co-glycolic acid) carrying exenatide to overcome the mucus barrier and improve intestinal targeting efficiency.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Zhang X; Sun K
    Nanomedicine (Lond); 2019 Apr; 14(8):989-1009. PubMed ID: 31088322
    [No Abstract]   [Full Text] [Related]  

  • 34. Size shifting of solid lipid nanoparticle system triggered by alkaline phosphatase for site specific mucosal drug delivery.
    Le-Vinh B; Steinbring C; Wibel R; Friedl JD; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2021 Jun; 163():109-119. PubMed ID: 33775852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
    Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
    Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
    Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S
    J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide?
    Dumont C; Beloqui A; Miolane C; Bourgeois S; Préat V; Fessi H; Jannin V
    Int J Pharm; 2020 Aug; 586():119581. PubMed ID: 32603838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.
    Beloqui A; Solinís MÁ; des Rieux A; Préat V; Rodríguez-Gascón A
    Int J Pharm; 2014 Jul; 468(1-2):105-11. PubMed ID: 24746410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles.
    Liu D; Bimbo LM; Mäkilä E; Villanova F; Kaasalainen M; Herranz-Blanco B; Caramella CM; Lehto VP; Salonen J; Herzig KH; Hirvonen J; Santos HA
    J Control Release; 2013 Sep; 170(2):268-78. PubMed ID: 23756152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol.
    Prezotti FG; Boni FI; Ferreira NN; Silva DS; Almeida A; Vasconcelos T; Sarmento B; Gremião MPD; Cury BSF
    Drug Dev Ind Pharm; 2020 Feb; 46(2):236-245. PubMed ID: 31928345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.